<!DOCTYPE html><html prefix="og: http://ogp.me/ns#" lang="zh">
<!-- Mirrored from cn.nytimes.com/business/20130101/c01genomics/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:18:15 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head><meta charset="UTF-8"><!-- Browser render  --><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta name="renderer" content="webkit"><!-- End Browser render --><meta name="keywords" content=""><meta name="description" content="深圳华大基因对加州完整基因的收购案充满争议，一些科学家、政界人士和业界高管称，这将威胁美国在DNA测序领域的竞争力。"><meta id="uuid" name="uuid" content="0e48be26781a30ca06d8fc500eccb769"><meta id="headline" name="headline" content="美国批准中方收购DNA测序公司 - 世界经济观察报中文网"><meta id="byline" name="byline" content="ANDREW POLLACK"><meta id="date" name="date" content="2013-01-01T09:17:48.000Z"><link rel="alternate" href="../index.html" hreflang="zh-Hans"><link rel="alternate" href="../zh-hant/index.html" hreflang="zh-Hant"><link rel="canonical" href="../index.html"><link rel="alternate" type="application/rss+xml" href="https://cn.nytimes.com/rss/"><meta name="apple-itunes-app" content="app-id=807498298, app-argument=nytimescn://article:0e48be26781a30ca06d8fc500eccb769"><meta name="lang" property="lang" content="zh-cmn-hans"><!-- Apple IOS safari private meta --><link rel="apple-touch-icon-precomposed" sizes="144×144" href="../../../../../static01.nyt.com/images/icons/ios-ipad-144x144.png"><link rel="apple-touch-icon-precomposed" sizes="114×114" href="../../../../../static01.nyt.com/images/icons/ios-iphone-114x144.png"><link rel="apple-touch-icon-precomposed" href="../../../../../static01.nyt.com/images/icons/ios-default-homescreen-57x57.png"><meta name="apple-mobile-web-app-title" content="美国批准中方收购DNA测序公司 - 世界经济观察报中文网"><meta name="apple-mobile-web-app-capable" content="yes"><!-- End Apple IOS safari private meta --><!-- Viewport and mobile --><meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no,maximum-scale=1,minimum-scale=1,minimal-ui"><!-- End viewport and mobile --><meta http-equiv="Cache-Control" content="no-siteapp"><meta name="format-detection" content="telephone=no"><meta name="HandheldFriendly" content="true"><meta name="MobileOptimized" content="320"><meta name="x5-orientation" content="portrait"><meta name="full-screen" content="yes"><meta name="x5-fullscreen" content="true"><meta name="browsermode" content="application"><meta name="x5-page-mode" content="app"><meta name="msapplication-tap-highlight" content="no"><meta property="og:title" content="美国批准中方收购DNA测序公司"><meta property="og:type" content="article"><meta property="og:url" content="../index.html"><meta property="og:description" content="深圳华大基因对加州完整基因的收购案充满争议，一些科学家、政界人士和业界高管称，这将威胁美国在DNA测序领域的竞争力。"><meta property="og:site_name" content="世界经济观察报中文网"><meta property="article:publisher" content="https://www.facebook.com/nytimeschinese"><meta property="article:published_time" content="2013-01-01T09:17:48.000Z"><meta property="fb:pages" content="354478527979178"><meta property="fb:app_id" content="1752616314982485"><meta property="og:image" content="../../../../../static01.nyt.com/images/2012/12/31/business/jpGENOMICS/jpGENOMICS-articleLarge.html"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:url" content="../index.html"><meta property="twitter:title" content="美国批准中方收购DNA测序公司"><meta property="twitter:description" content="深圳华大基因对加州完整基因的收购案充满争议，一些科学家、政界人士和业界高管称，这将威胁美国在DNA测序领域的竞争力。"><meta property="twitter:domain" content="cn.nytimes.com"><meta property="twitter:site" content="@nytchinese"><meta property="twitter:creator" content="@nytchinese"><meta property="twitter:image:src" content="../../../../../static01.nyt.com/images/2012/12/31/business/jpGENOMICS/jpGENOMICS-articleLarge.html"><meta name="PT" content="article"><meta name="PST" content="News"><meta name="CG" content="business"><meta name="SCG" content=""><meta name="sourceApp" content="nyt-china-web"><meta name="ptime" content="20130101021755"><meta name="utime" content="20130101091748"><meta name="pdate" content="20130101"><meta name="dat" content="Jan. 01, 2013"><meta name="hdl" content="美国批准中方收购DNA测序公司"><meta name="byl" content="ANDREW POLLACK"><meta name="lp" content="深圳华大基因对加州完整基因的收购案充满争议，一些科学家、政界人士和业界高管称，这将威胁美国在DNA测序领域的竞争力。"><link rel="shortcut icon" href="https://static01.nyt.com/favicon.ico"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/style-flex.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/web/style.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/article.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/slideshow/slideshow.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/cookie-banner/style.min619b.css?v=f1810d8"><title>美国批准中方收购DNA测序公司 - 世界经济观察报中文网</title></head><script>var js_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/js";
 var imgs_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style/imgs";
 var style_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style";
 var site = 1;
 var sectionName = "business";
 var adTyp = "art";
 var cookieString = {
     "title": "您的跟踪器设置",
     "headline": "我们使用 cookie 做什么？",
     "summary": '<p>我们利用cookies和类似的技术识别您的重复访问和偏好。我们还使用它们来衡量广告系列的效果，定位广告并分析和网站流量。更多关于cookies的信息（包括如何停用），<a id="JSCookiePolicyLink" href="https://www.nytimes.com/zh-hans/privacy/cookie-policy" rel="noreferrer noopener" target="_blank" data-testid="GDPR-policy">请查看我们的“Cookie政策”</a>。</p><p>自2020年7月20日起，我们将根据您在我们服务中所访问的内容类型向您显示我们认为与您的兴趣相关的广告。您可以<a href="https://www.nytimes.com/zh-hans/privacy/cookie-policy#how-do-i-manage-trackers" rel="noreferrer noopener" target="_blank" data-testid="GDPR-objection">提出反对</a>。希望了解更多信息，请参见我们的<a href="https://nytimes.com/zh-hans/privacy/privacy-policy#we-allow-for-personalized-advertising-on-times-services" rel="noreferrer noopener" target="_blank" data-testid="GDPR-privacy">隐私政策</a>。</p><p>通过在此处点击“我接受”或者“X”，您将被视为同意使用cookies。您随时可以通过我们的Cookie政策来更改您的跟踪器偏好。</p>',
     "button": "接受",
     "trackerButton": "您的跟踪器设置",
     "rejectButton": "拒绝所有",
     "lang": 'zh-hans',
     "trackerLink": "https://www.nytimes.com/zh-hans/privacy/cookie-policy",
 };
 var purrString = {
     "button": "请勿出售我的个人信息",
     "snackbar": "你的设置已经保存在此浏览器和设备上。如果你清除了 cookie，这些设置也会被清除。",
     "snackbarError": "Something went wrong",
     "optedOutText": "我们不再出售您的个人信息",
     "CFALinkText": "California Notices",
     "purrPopupTitle": "Your request to not sell your data will be stored for this browser and device",
     "purrPopupSummary": "If you clear your cookies, your preference will be forgotten. As a California resident, you have additional rights under the California Consumer Privacy Act of 2018. While The New York Times Company does not “sell” personal information of its readers as the term “sell” is traditionally understood, “sell” under the CCPA is broadly defined. To learn more, review the text below.",
     "purrPopupButton": "DISMISS",
     "purrPopupScrollContent": '<p>The New York Times Company does not sell personal information of its readers as the term “sell” is traditionally understood. But “sell” under the CCPA is broadly defined. It includes the sharing of personal information with third parties in exchange for something of value, even if no money changes hands. For example, sharing an advertising or device identifier to a third party may be considered a “sale” under the CCPA. </p><p>To the extent The New York Times Company “sells” your personal information (as the term “sell” is defined under the CCPA), you have the right to opt-out of that “sale” on a going-forward basis at any time. To exercise this right, click the “Do Not Sell My Personal Information” link in the footer of our website or under your “Account,” which you have already done. You can also submit a request to opt-out by emailing us at privacy@nytimes.com with the subject line “California Resident - Do Not Sell.”</p><p>Once you have opted out, you will see a change to “We No Longer Sell Your Personal Information.” If you have an account with certain Times Services (specifically nytimes.com, cooking.nytimes.com, nytimes.com/crosswords, the New York Times app, the New York Times Cooking app and the New York Times Crossword app) and are logged in, we will save your preference and honor your opt-out request across browsers and devices so long as you remain logged in. If you are not logged in, or do not have an account with any Times Services listed above, your opt-out of the “sale” of personal information will be specific to the browser or device from which you have clicked “Do Not Sell My Personal Information” and until you clear your cookies (or local storage in apps) on this browser or device. </p><p>If your browser or device is using a “do not track” setting, we will detect it and honor it on that specific browser or device only. If you wish to have a “do not track” experience across all of your browsers and devices, please make sure that all of your browsers and devices are set on “do not track.”</p><p>After you opt out of the “sale” of your personal information, we will no longer “sell” your personal information to third parties (except in an aggregated or de-identified manner so it is no longer personal information), but we will continue to share your personal information with our service providers, which process it on our behalf. Exercising your right to opt out of the “sale” of your personal information does not mean that you will stop seeing ads on our sites and apps. </p><p>To opt-out of interest-based advertising as much as technically possible, go to <a href="http://www.nytimes.com/privacy/cookie-policy#how-do-i-manage-trackers" target="_blank">“How Do I Manage Trackers”</a> in our Cookie Policy. To opt out of the “sale” of your personal information from participating companies, please visit the Digital Advertising Alliance <a href="https://optout.privacyrights.info/?c=1" target="_blank">website</a> or <a href="https://www.privacyrights.info/appchoices" target="_blank">apps</a>. We do not control these opt-out mechanisms and are not responsible for their operation.</p><p>You can designate someone else to make a request on your behalf. To protect your information, we will ask for a signed permission from you authorizing the other person to submit a request on your behalf. We will contact you to verify your identity before we respond to your authorized agent’s request.<p/><p>After 12 months, we may ask you if you want to opt into the “sale” of your personal information.</p><p>For further information, please refer to our <a href="http://www.nytimes.com/privacy/privacy-policy" target="_blank">Privacy Policy.</a></p>',
     "lang": 'zh-hans'
 };
 cbSectionName = "business";
 cbByline = "ANDREW POLLACK";</script><!-- Google Tag Manager --><script>(function(w,d,s,l,i){
     w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});
     var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
     j.async=true;j.src='../../../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;
     f.parentNode.insertBefore(j,f);
 })(window,document,'script','dataLayer','GTM-KTDZV8V');</script><!-- End Google Tag Manager --><!-- chartbeat --><script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script><!-- /chartbeat --><body class="news"><main class="container-fluid main clearfix"><header class="row title-bar"><div class="nav-button default" id="menuBtn"><i class="icon-bars"></i></div><h1 class="logo"><a href="/"><svg role="img" aria-label="" width="90%" height="90%"><image width="100%" height="100%" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="/d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hans%402x.png" src="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hans%402x.png" alt="" border="0"></image></svg></a></h1><div class="nav-button default" id="gearBtn"><i class="icon-gear"></i></div><div class="popup gear-popup"><div class="tips-container"><div class="tips-border"></div><div class="tips-inner"></div></div><div class="popup-container"><div class="popup-body"><div class="setting-title">简繁中文</div><div class="setting-option"><a href="../index024e.html?changeLang=zh-hans" class="active">简体 </a><a href="../index27d8.html?changeLang=zh-hant">繁体</a></div><div class="setting-title">世界经济观察报 出版语言</div><ul class="menu-list"><li><a href="https://www.nytimes.com/">ENGLISH (英语)</a></li><li><a href="https://www.nytimes.com/es/">ESPAÑOL (西班牙语)</a></li></ul><div class="setting-title">字体大小</div><div class="setting-option"><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="small"> 小</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="normal" checked="checked"> 中</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="large"> 大</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="xlarge"> 超大</label></div></div></div></div></div></header><div class="top_banner_ad" id="topad" data-target="{&quot;pos&quot;:&quot;top&quot;,&quot;adv&quot;:&quot;&quot;}"></div><div class="article-area"><div class="setting-bar row"><div class="col-4 section-title"><h3>商业与经济</h3></div><div class="col-8 setting-btns"><div class="row"><div class="col-6"><ul class="dual-btn"><li><a href="../index.html"><span class="setting-btn-text">中文</span> <span class="setting-btn-text-mobile">中</span></a></li><li><a href="javascript:;" class="active"><span class="setting-btn-text">中英双语</span> <span class="setting-btn-text-mobile">双语</span></a></li><li><a href="#" target="_blank"><span class="setting-btn-text">英文 <i class="icon-share-square"></i> </span><span class="setting-btn-text-mobile">英</span></a></li></ul></div><div class="col-6 share-tools-top-container"><ul class="share-tools mobile-article"><li><a href="http://v.t.sina.com.cn/share/share.php?&amp;title=%E7%BE%8E%E5%9B%BD%E6%89%B9%E5%87%86%E4%B8%AD%E6%96%B9%E6%94%B6%E8%B4%ADDNA%E6%B5%8B%E5%BA%8F%E5%85%AC%E5%8F%B8&amp;url=https://cn.nytimes.com/business/20130101/c01genomics/" target="_blank"><i class="icon-weibo"></i></a></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20130101/c01genomics/" data-headline="%E7%BE%8E%E5%9B%BD%E6%89%B9%E5%87%86%E4%B8%AD%E6%96%B9%E6%94%B6%E8%B4%ADDNA%E6%B5%8B%E5%BA%8F%E5%85%AC%E5%8F%B8"> --><!-- <i class="icon-wechat"></i> --><!-- </a> --><!-- </li> --><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://cn.nytimes.com/business/20130101/c01genomics/" trage="_blank"><i class="icon-facebook"></i></a></li><li><a href="https://plus.google.com/share?url=https://cn.nytimes.com/business/20130101/c01genomics/" target="_blank"><i class="icon-google"></i></a></li><li><a href="https://twitter.com/share?text=%E7%BE%8E%E5%9B%BD%E6%89%B9%E5%87%86%E4%B8%AD%E6%96%B9%E6%94%B6%E8%B4%ADDNA%E6%B5%8B%E5%BA%8F%E5%85%AC%E5%8F%B8&amp;url=https://cn.nytimes.com/business/20130101/c01genomics/" target="_blank"><i class="icon-twitter"></i></a></li><li><div class="line-it-button" data-lang="zh_Hant" data-type="share-g" data-url="https://cn.nytimes.com/business/20130101/c01genomics/" style="display: none;"></div><script src="/d.line-scdn.net/r/web/social-plugin/js/thirdparty/loader.min.js" async="async" defer="defer"></script></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20130101/c01genomics/" data-headline="%E7%BE%8E%E5%9B%BD%E6%89%B9%E5%87%86%E4%B8%AD%E6%96%B9%E6%94%B6%E8%B4%ADDNA%E6%B5%8B%E5%BA%8F%E5%85%AC%E5%8F%B8"> --><!-- <i class="icon-qrcode"></i> --><!-- </a> --><!-- </li> --></ul><div class="share-btn"><i class="icon-forward"></i></div></div></div></div></div><article class="article-content article-dual font-normal"><div class="article-header"><header><small></small><h1>美国批准中方收购DNA测序公司</h1><h1 class="en-title">U.S. Clears DNA Firm’s Acquisition by Chinese</h1></header><div class="byline-row"><div class="byline-box"><div class="byline"><address>ANDREW POLLACK</address><time pudate="2013-01-01 09:17:48" datetime="2013-01-01 09:17:48">2013年1月1日</time></div><div class="share-btn"><i class="icon-forward"></i></div></div></div></div><figure class="article-span-photo"><img src="../../../../../static01.nyt.com/images/2012/12/31/business/jpGENOMICS/jpGENOMICS-jumbo.html" width="1024" height="613" alt="加利福尼亚州完整基因公司的DNA测序仪。该公司否认了有关并购的种种担忧。"><figcaption><span>加利福尼亚州完整基因公司的DNA测序仪。该公司否认了有关并购的种种担忧。</span> <cite>Ramin Rahimian</cite></figcaption></figure><div class="row"><section class="article-body"><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The federal government has given national security clearance to the controversial purchase of an American DNA sequencing company by a Chinese firm.</div></div><div class="col-lg-6"><div class="article-paragraph">一家中国企业对一家美国DNA测序公司充满争议的收购案，通过了美国联邦政府的国家安全审查。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The Chinese firm, BGI-Shenzhen, said in a statement this weekend that its acquisition of Complete Genomics, based in Mountain View, Calif., had been cleared by the federal Committee on Foreign Investment in the United States, which reviews the national security implications of foreign takeovers of American companies. The deal still requires antitrust clearance by the Federal Trade Commission.</div></div><div class="col-lg-6"><div class="article-paragraph">中国企业深圳华大基因(BGI)在上周末的一份声明中称，它对于加州山景市的完整基因公司(Complete Genomics)的收购，已经得到了联邦机构美国外国投资委员会(Committee on Foreign Investment in the United States)的批准。该委员会负责审查外国企业对美国企业的收购带来的国家安全影响。不过这笔交易仍需通过美国联邦贸易委员会(Federal Trade Commission)的反垄断审查。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Some scientists, politicians and industry executives had said the takeover represented a threat to American competitiveness in DNA sequencing, a technology that is becoming crucial for the development of drugs, diagnostics and improved crops.</div></div><div class="col-lg-6"><div class="article-paragraph">一些科学家、政界人士和业界高管声称，这次收购将对美国在DNA测序领域的竞争力造成威胁。DNA测序技术在药物、诊断学和农作物改良的研发过程中的作用日益重要。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The fact that the $117.6 million deal was controversial at all reflects a change in the genomics community.</div></div><div class="col-lg-6"><div class="article-paragraph">事实上，这笔价值1.176亿美元（约合7.3亿元人民币）的交易产生争议本身反映了基因界的一次转变。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">A decade ago, the Human Genome Project, in which scientists from many nations helped unravel the genetic blueprint of mankind, was celebrated for its spirit of international cooperation. One of the participants in the project was BGI, which was then known as the Beijing Genomics Institute.</div></div><div class="col-lg-6"><div class="article-paragraph">10年前，由各国科学家共同参与绘制人类基因蓝图的人类基因组计划(Human Genome Project)曾因其国际合作精神而受到赞扬。华大基因曾是该计划的参与者之一，当时称为北京基因组研究所。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">But with DNA sequencing now becoming a big business and linchpin of the biotechnology industry, international rivalries and nationalism are starting to move front and center in any acquisition.</div></div><div class="col-lg-6"><div class="article-paragraph">但是，随着DNA测序现在成为了一门大生意，也成了生物技术产业的关键，国际竞争和民族主义开始在所有收购案中占据核心位置。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Much of the alarm about the deal has been raised by Illumina, a San Diego company that is the market leader in sequencing machines. It has potentially the most to lose from the deal because BGI might buy fewer Illumina products and even become a competitor. Weeks after the BGI deal was announced, Illumina made its own belated bid for Complete Genomics, offering 15 cents a share more than BGI’s bid of $3.15. But Complete Genomics rebuffed Illumina, saying such a merger would never clear antitrust review.</div></div><div class="col-lg-6"><div class="article-paragraph">对这次交易的大部分警告来自Illumina公司。这家位于圣迭戈的公司是基因测序设备生产业的行业领先者。这家公司可能是这次交易的最大受害者，因为华大或许会减少Illumina产品的购买量，甚至成为一个竞争对手。在华大基因交易宣布数周后，Illumina也姗姗来迟地向完整基因公司提出了自己的收购要约，比华大基因开出的每股3.15美元要高出15美分。但完整基因公司断然回绝了Illumina，称这样的收购将绝不可能通过反垄断审查。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Illumina also hired a Washington lobbyist, the Glover Park Group, to stir up opposition to the deal in Congress. Representative Frank R. Wolf, Republican of Virginia, was the only member of Congress known to have publicly expressed concern.</div></div><div class="col-lg-6"><div class="article-paragraph">Illumina还雇佣了华盛顿游说机构格洛弗帕克集团(Glover Park Group)，在国会中搅动起对这次交易的反对。弗吉尼亚州共和党人、众议员弗兰克·R·沃尔夫(Frank R. Wolf)，是唯一公开对此表示出担忧的一位议员。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">BGI and Complete Genomics point out that Illumina has long sold its sequencing machines — including a record-setting order of 128 high-end machines — to BGI without raising any security concerns. Sequencing machines have not been subject to export controls like aerospace equipment, lasers, sensors and other gear that can have clear military uses.</div></div><div class="col-lg-6"><div class="article-paragraph">华大基因和完整基因指出，Illumina曾长期向华大基因出售其基因测序仪器，其中一次售出了128部高端仪器创下了纪录，而当时并未引起任何安全担忧。基因测序仪器并不属于美国出口限制商品。出口限制商品包括航空航天设备、激光设备、传感器和其他可能具有明确军事用途的仪器设备。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“Illumina has never previously considered its business with BGI as ‘sensitive’ in the least,” Ye Yin, the chief operating officer of BGI, said in a November letter to Complete Genomics that was made public in a regulatory filing. In the letter, Illumina was accused of “obvious hypocrisy.”</div></div><div class="col-lg-6"><div class="article-paragraph">华大基因首席运营官尹烨在11月发送给完整基因公司的一封信件中说，“Illumina此前从来没有考虑过，它与华大的交易是‘敏感的’。”这封信件是在向监管部门提交的文件中披露的。信中指责Illumina，“明显的虚伪”。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">BGI and Complete said that Illumina was trying to derail the agreement and acquire Complete Genomics itself in order to “eliminate its closest competitor, Complete.”</div></div><div class="col-lg-6"><div class="article-paragraph">华大基因和完整基因称，Illumina试图破坏协议，并自行收购完整基因，从而达到“消灭完整基因这个实力最接近的竞争对手”的目的。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">BGI is already one of the most prolific DNA sequencers in the world, but it buys the sequencing machines it uses from others, mainly Illumina.</div></div><div class="col-lg-6"><div class="article-paragraph">华大基因已经是世界上最多产的DNA测序机构之一，但它使用的测序仪器却从别家购买，主要来自Illumina公司。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Illumina, joined by some American scientists, said it worried that if BGI gained access to Complete’s sequencing technology, the Chinese company might use low prices to undercut the American sequencing companies that now dominate the industry.</div></div><div class="col-lg-6"><div class="article-paragraph">Illumina以及一些美国科学家都表示，他们担心如果华大基因能够接触到完整基因的测序技术，这家中国公司或许会以低价抢夺美国测序公司的生意，而这些公司目前主导着测序行业。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Some also said that with Complete Genomics providing an American base, BGI would have access to more DNA samples from Americans, helping it compile a huge database of genetic information that could be used to develop drugs and diagnostic tests. Some also worried about protection of the privacy of genetic information.</div></div><div class="col-lg-6"><div class="article-paragraph">也有一些人说，有了完整基因提供的美国数据库，华大基因将能接触到更多的来自美国人的DNA样本，这将有助于华大基因编制巨大的遗传信息数据库，可用于开发新药和诊断性医疗检查。还有人担心如此一来，难以保障遗传信息的隐私。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“What’s to stop them from mining genomic data of American samples to some unknown nefarious end?” Elaine R. Mardis, co-director of the genome sequencing center at Washington University in St. Louis, said in an e-mail.</div></div><div class="col-lg-6"><div class="article-paragraph">“有什么能阻止他们利用美国人样本的基因组数据，去达到未知的邪恶目的？”圣路易斯华盛顿大学(Washington University in St. Louis)基因组序列中心联合主任伊莱恩·R·玛蒂斯(Elaine R. Mardis)在一封邮件中说道。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Dr. Mardis could not specify what kind of nefarious end she imagined. But opponents of the deal cited a <a title="Atlantic article on hacking presidential DNA." href="http://www.theatlantic.com/magazine/archive/2012/11/hacking-the-presidents-dna/309147/" rel="noopener noreferrer">November article in The Atlantic</a> saying that in the future, pathogens could be genetically engineered to attack particular individuals, including the president, based on their DNA sequences.</div></div><div class="col-lg-6"><div class="article-paragraph">玛蒂斯不能具体说明她所能想象的邪恶目的会有哪些。但是这笔交易的反对者引用了《大西洋月刊》(The Atlantic)11月的一篇文章，说可以对病原体进行基因改造，根据个体的DNA序列，对人实施攻击，潜在的受害者可能包括总统。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">BGI and Complete Genomics dismissed such concerns as preposterous.</div></div><div class="col-lg-6"><div class="article-paragraph">华大基因和完整基因对这些担忧不以为然，说它们荒唐可笑。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“There is absolutely no basis for such a wild and speculative claim” about biological weapons, Clifford A. Reid, the chief executive of Complete Genomics, said in a regulatory filing.</div></div><div class="col-lg-6"><div class="article-paragraph">完整基因的首席执行官克利福德·A·里德(Clifford A. Reid)在一份监管文件中说道，有关生物武器的“疯狂的、异想天开的说法毫无根据”。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">BGI already is doing sequencing of American DNA samples with partners including the Children’s Hospital of Philadelphia and the patient-advocacy group Autism Speaks. BGI said any sequencing intended for medical use of American patients would be done in the United States in accordance with American laws regarding clinical research and patient privacy.</div></div><div class="col-lg-6"><div class="article-paragraph">华大基因已经在和一些合作伙伴进行美国人类DNA样本的测序，其中包括美国费城儿童医院(Children's Hospital of Philadelphia)和病人权益倡导组织“自闭症之声”(Autism Speaks)。华大基因说，任何针对美国患者的以医疗为目的的测序都会在美国进行，并遵循美国有关临床研究和患者隐私的法律。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Some other executives at American sequencer manufacturers said they saw no cause for concern. “I can’t believe they can come up with a rational explanation of why this is a national security issue,” said Michael W. Hunkapiller, the chief executive of Pacific Biosystems.</div></div><div class="col-lg-6"><div class="article-paragraph">其他一些美国测序仪生产企业的高管们说，他们认为没有必要担心。“我不相信他们能合理地解释，这为什么会是一个国家安全问题，”太平洋生物系统公司(Pacific Biosystems)的首席执行官迈克尔·W·亨克皮勒(Michael W. Hunkapiller)说道。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Jonathan M. Rothberg, who runs the Ion Torrent sequencer division of Life Technologies, also said the acquisition “does not appear to raise national security issues.”</div></div><div class="col-lg-6"><div class="article-paragraph">生命技术公司(Life Technologies)离子激流(Ion Torrent)测序仪的负责人乔纳森·M·罗思伯格(Jonathan M. Rothberg)也说，这次并购“看不出会引发任何国家安全问题”。 </div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Jay T. Flatley, the chief executive of Illumina, said there was a difference between selling sequencing machines and selling sequencing technology. He compared it selling someone a Coke and selling the formula to make Coca-Cola.</div></div><div class="col-lg-6"><div class="article-paragraph">Illumina公司的首席执行官杰伊·T·弗拉特利(Jay T. Flatley)说，出售测序仪器和出售测序技术不同。他说，这就好比卖给某人一瓶可乐，和出售生产可口可乐的配方之间的区别。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“Providing access to the fundamental technology is entirely different,” he said in an e-mail Friday. “It would allow funding from the Chinese government to move the technology forward at a pace that no U.S. company could match because we do not have access to such funding sources.”</div></div><div class="col-lg-6"><div class="article-paragraph">“提供基础技术完全是另一回事，”他周五在一封邮件里说道，“这笔并购将使得来自中国政府的资金推动此类科技向前发展，这是美国公司无法企及的，因为我们没有这样的资金渠道。”</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Illumina has characterized BGI as an entity of the Chinese government. BGI denies that, saying it is a private company owned by its employees.</div></div><div class="col-lg-6"><div class="article-paragraph">Illumina将华大基因描述为中国政府的公司。华大基因予以否认，表示华大为私有企业，所有权属于其员工。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Complete Genomics, while it makes it own sequencing machines, does not sell them to others. Rather, it offers sequencing as a service. Its customers have included the National Cancer Institute, Genentech and the Mayo Clinic.</div></div><div class="col-lg-6"><div class="article-paragraph">完整基因虽然制造自己的测序仪器，但并不出售。相反的，它提供测序的服务。它的客户包括美国国家癌症研究所(National Cancer Institute)、基因泰克(Genentech)和梅约诊所(Mayo Clinic)。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Mr. Hunkapiller of Pacific Biosciences said Complete’s technology is “very slow.”</div></div><div class="col-lg-6"><div class="article-paragraph">太平洋生物系统公司的亨克皮勒说，完整基因的技术“很慢”。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">He said of Illumina: “I can’t believe they are worried about Complete’s technology taking them out. That’s nuts.”</div></div><div class="col-lg-6"><div class="article-paragraph">关于Illumina，他说：“我不相信他们会担心完整基因的技术把他们挤垮。那是疯话。”</div></div></div></div><div class="article-body-aside col-lg-3"></div></div></section></div><div class="col-lg-12 row author-info-container"><footer class="author-info"><p>翻译：曹莉、林蒙克</p></footer></div></article><div class="container article-footer"><div class="row"><div class="col-lg-12 dual-refer-cont"><div class="related-cont"><h4>相关报道</h4><ul class="refer-list"><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/health/20120910/c10genesecret/" title="基因测试结果，不能说的秘密"><div><h3 class="refer-list-headline">基因测试结果，不能说的秘密</h3><p class="refer-pubdate">2012年9月10日</p></div><img alt="基因测试结果，不能说的秘密" src="../../../../../static01.nyt.com/images/2012/08/26/us/GENES-3/GENES-3-thumbLarge.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/health/20120820/c20cancerone/" title="医学新突破：基因测序发现血癌元凶"><div><h3 class="refer-list-headline">医学新突破：基因测序发现血癌元凶</h3><p class="refer-pubdate">2012年8月20日</p></div><img alt="医学新突破：基因测序发现血癌元凶" src="../../../../../static01.nyt.com/images/2012/07/08/health/gamble/gamble-thumbLarge.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/science/20120615/c15genome/" title="基因测序廉价化有助医学进步"><div><h3 class="refer-list-headline">基因测序廉价化有助医学进步</h3><p class="refer-pubdate">2012年6月15日</p></div></a></div></li></ul></div></div><div class="col-lg-12"><div class="related hot_article"><h5 class="related-title">最受欢迎</h5><ol class="related-articles"><li><a href="#https://cn.nytimes.com/usa/20220127/computer-chip-shortage-taiwan/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>战棋推演报告称台湾半导体工厂停产可能引发中美冲突</h4><img alt="战棋推演报告称台湾半导体工厂停产可能引发中美冲突" src="../../../../../static01.nyt.com/images/2022/01/26/us/politics/26dc-wargames/merlin_177315390_5fcf8532-e370-4f81-8f99-45c6c83044f4-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/pakistan-united-states-china/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>“巴铁”军方为什么想与中国保持距离？</h4><img alt="“巴铁”军方为什么想与中国保持距离？" src="../../../../../static01.nyt.com/images/2022/01/24/opinion/21Rafiq1/21Rafiq1-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220126/china-covid-19/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>中国追求“清零”将把国家置于灾难之中</h4><img alt="中国追求“清零”将把国家置于灾难之中" src="../../../../../static01.nyt.com/images/2022/01/25/opinion/25emanuel/25emanuel-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/sports/20220127/peng-shuai-china-australian-open/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>澳网再现“彭帅在哪里”：球员和观赛者拒绝遗忘、为其发声</h4><img alt="澳网再现“彭帅在哪里”：球员和观赛者拒绝遗忘、为其发声" src="../../../../../static01.nyt.com/images/2022/01/26/sports/26aus-china1/merlin_199503951_9c695f25-2b8e-41b4-9c97-bf91de7aa190-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220125/gang-chen-mit-china/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>“我们在残害我们自己”：华裔教授陈刚案背后的愤怒与幻灭</h4><img alt="“我们在残害我们自己”：华裔教授陈刚案背后的愤怒与幻灭" src="../../../../../static01.nyt.com/images/2022/01/24/science/24CHEN-promo/24CHEN-promo-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/virtual-reality-simulation/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>我们可能活在模拟现实中，人类应该多担忧这件事？</h4><img alt="我们可能活在模拟现实中，人类应该多担忧这件事？" src="../../../../../static01.nyt.com/images/2022/01/26/opinion/26manjoo-image/26manjoo-image-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/winter-olympics-china-beijing-xi-jinping/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>不再取悦世界：一届展现习近平全面愿景的冬奥会</h4><img alt="不再取悦世界：一届展现习近平全面愿景的冬奥会" src="../../../../../static01.nyt.com/images/2022/01/13/world/00xi-olympics-30/00xi-olympics-30-thumbLarge.jpg"></article></a></li><li><a href="../../../20220126/imf-world-economic-report/indexf61c.html?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>国际货币基金组织称中美经济放缓将拖累全球经济</h4><img alt="国际货币基金组织称中美经济放缓将拖累全球经济" src="../../../../../static01.nyt.com/images/2022/01/25/multimedia/25global-econ-brf/25global-econ-brf-thumbLarge-v2.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/asia-pacific/20220126/north-korea-launches-missiles-kim/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>朝鲜突然频繁试射导弹传递了什么信息？</h4><img alt="朝鲜突然频繁试射导弹传递了什么信息？" src="../../../../../static01.nyt.com/images/2022/01/21/world/00nkorea-gameplan-01/00nkorea-gameplan-01-thumbLarge.html"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/china-zero-covid-policy/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>多地封锁引发沮丧与抱怨，中国“清零”政策还能走多远？</h4><img alt="多地封锁引发沮丧与抱怨，中国“清零”政策还能走多远？" src="../../../../../static01.nyt.com/images/2022/01/20/world/00virus-china-lockdown-01/00virus-china-lockdown-01-thumbLarge.html"></article></a></li></ol></div></div></div></div></div><footer class="row copy-footer">&copy; 2022 The World Economy Observer.<ul class="footerLinkList"><li class="footerLink"><a rel="nofollow" href="/ad/">广告</a></li><li class="footerLink"><a rel="nofollow" href="/about-us/">关于我们</a></li><li class="footerLink"><a rel="nofollow" href="/contact/">联系我们</a></li><li class="footerLink"><a rel="nofollow" href="/tos/">服务条款</a></li><li class="purr-content"></li></ul></footer><script src="/d1f1eryiqyjs0r.cloudfront.net/js/libs/require619b.js?v=f1810d8"></script><script src="/d1f1eryiqyjs0r.cloudfront.net/js/web/article.min619b.js?v=f1810d8"></script></main></body>
<!-- Mirrored from cn.nytimes.com/business/20130101/c01genomics/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:18:15 GMT -->
</html>